Navigation Links
Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
Date:6/3/2008

al cancer; CPX-351 (a liposomal formulation of cytarabine:daunorubicin), currently in a Phase 1 trial in patients with leukemia; CPX 571 (a liposomal formulation of irinotecan:cisplatin), a preclinical stage compound; and multiple research programs. Based on the applications of CombiPlex, Celator is positioned to advance a broad pipeline of combination therapies involving both previously approved and novel drug agents. For more information, please visit the company's website at http://www.celatorpharma.com.


'/>"/>
SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
2. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
3. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
4. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
5. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
6. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
9. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
10. Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting
11. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014 With ... (MRI), the MRI market is seeing new growth, ... breast MRI scans account for the majority of ... higher resolution of images, which are creating opportunities for ... (MRI) market is growing at a rate of ...
(Date:12/17/2014)... , The new Dompé website aims ... the biopharmaceutical Group,s national and international clinical research activities ... launched institutional website that is receiving accolades from all over ... chapter in the fascinating story of Drug Discovery   , ... on the world of clinical research, ranging from information for ...
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. ... the closing of its offering of $125 million aggregate ... (the "Notes").  The Notes were offered and sold only ... the Securities Act of 1933, as amended (the "Securities ... fixed rate of 3.75% per year, payable semiannually in ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... the human antibody,therapeutics company, announced today that preclinical ... presented by its,collaboration partner Peregrine Pharmaceuticals at the ... Research (AACR) 2009 held during April,18 - 22, ... PGN635 and PGN632,provided further confirmatory evidence that the ...
... Minutes Direct from Positive Blood CulturesFaster Results to Help ... Mass. and VEDBAEK, Denmark, April 28 AdvanDx today ... protocol for all CE-IVD marked PNA FISH(R) tests in ... turn-around time from the original 2.5 hours to 90 ...
Cached Medicine Technology:Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies 2AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe 2AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe 3
(Date:12/19/2014)... 19, 2014 Silver Dollar City ... record -- for the first time ever, Silver Dollar City ... Guinness World Records 2015, listing the park’s wood coaster Outlaw ... In additional awards announced this week, Silver Dollar City is ... in the US,” USA Today’s 10Best awards for “Best Public ...
(Date:12/19/2014)... 2014 The Medspa at Hendrick in ... from respected cosmetic brand Juvéderm. Voluma XC treats volume ... The Medspa at Hendrick is pleased to be able ... technology to its clients. , Voluma is the first ... to treat the mid-face and cheek area. This non-invasive ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- Potentially illness-causing E. ... bought at farmers markets, according to a new study. ... 50 vendors from 13 farmers markets in Los Angeles ... area. Out of almost 150 samples tested, 24 percent ... for salmonella, according to the researchers. Both types ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Surviving Mesothelioma says ... EPA information indicates that these pipes can leach asbestos into ... to the full story on the Surviving Mesothelioma website. ... erosion of natural asbestos deposits, decaying water mains made of ... water. , To protect consumers from mesothelioma , ...
(Date:12/19/2014)... 19, 2014 The global magnetic ... equipment market that is saturated with numerous players ... efficacy as well as non-invasive nature, MRI systems ... introduced to the healthcare market. Rapid advances in ... MRI safe technologies have greatly expanded the potential ...
Breaking Medicine News(10 mins):Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 2Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 3Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 4
... symptoms worsened, too, study found , FRIDAY, Sept. 28 ... can aggravate asthma symptoms in kids, Canadian research suggests. ... British Columbia in Vancouver examined the degree of support ... peers. They also looked at social problems, such as ...
... of the,Connecticut Catholic Conference are an outrage and ... League. "It,s bad enough to allow,so-called emergency contraception ... has never officially ruled on such matters is ... statement that allows,personnel at Catholic hospitals to give ...
... (compulsive hair-pulling) affects between 2-4 % of,Americans -- ... yet remains little,known or understood by medical professionals ... is drawing attention to this,disorder with All Join ... October 1-7, 2007., All Join Hands 2007 ...
... warn Americans about risks of indoor tanning devices, ... important step,which may help reduce significantly the incidence ... the Tanning Accountability and,Notification Act (TAN Act) into ... Drug Administration Amendments Act of 2007 (HR 3580)," ...
... serving up flu shots for a third year in ... area restaurants, in,partnership with five community and health care ... getting the flu shot, not the flu. According ... Coast,Family Medicine and clinical spokesperson for Jacksonville,s third annual,Golden ...
... of patients responses to a drug used to control ... a U.S. Food and Drug Administration (FDA) warning against ... current issue of the journal Anesthesiology. , The FDA ... that the drug contributed to potentially fatal heart rhythm ...
Cached Medicine News:Health News:Trouble at Home Boosts Kids' Asthma 2Health News:Connecticut Catholic Conference Wrong to Allow 'Plan B' in Catholic Hospitals 2Health News:National Trichotillomania Awareness Week Gives Help and Hope to Hair-Pullers 2Health News:American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act 2Health News:Golden Corral's Good Health Recipe for the Flu Season 2Health News:Mayo Clinic study finds FDA warning against antinausea drug droperidol unnecessary 2
Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: